Sartorius | SRT3 - Cash And Equivalent

Stock Price
233.30
Daily Change
5.00 2.19%
Monthly
-10.27%
Yearly
-1.73%
Q1 Forecast
230.71

Sartorius reported EUR389.9M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 166.44M 29.14M Sep/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 975.3M 408.9M Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025